Novartis investing US$300m in next generation biotherapeutics development
The Swiss pharma giant is looking to bolster its capacity and capabilities for early technical development of biologics.
Archives for September 14, 2022
Novo Nordisk teams up with Microsoft for faster and scaled use of AI in drug discovery
Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud, and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development, and data science capabilities.